| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.34 | 0.06 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.26 | 0.07 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.26 | 0.07 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.1 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.21 | 0.1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.06 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.2 |